JMIR Bioinformatics and Biotechnology and JMIR Publications have announced the appointment of Dr. Ece Uzun as the new Editor-in-Chief for JMIR Bioinformatics and Biotechnology. Dr. Uzun brings with her a wealth of experience in bioinformatics and biotechnology, making her a valuable addition to the JMIR team.
Currently serving as the Director of Clinical Bioinformatics and Associate Director of Clinical Cancer Informatics and Data Science (CCIDS) at Lifespan and an Assistant Professor of Pathology and Laboratory Medicine at Brown University Alpert Medical School, Dr. Uzun has a strong analytical background and an extensive knowledge of bioinformatics and biotechnology. With a B.S in Chemical Engineering and M.Sc in Biological Sciences and Bioengineering, she went on to complete her PhD in Chemical Engineering at Northeastern University, focusing on mathematical modeling of drug delivery systems. During her postdoctoral training, she worked on computational genetics and bioinformatics, with a specific focus on neurodevelopmental disorders.
As the Director of Clinical Bioinformatics at Lifespan, Dr. Uzun is responsible for overseeing the bioinformatic analysis of Next Generation Sequencing (NGS) based clinical assays. She also performs research in the areas of bioinformatics tool and algorithm development, network biology, and machine learning-based predictive models with a specific focus on cancer and neurodevelopmental disorders. Her research team is composed of individuals from multiple disciplines and diverse backgrounds.
Dr. Uzun has previously served as an Associate Editor in two other journals, making her well-equipped to lead JMIR Bioinformatics and Biotechnology as Editor-in-Chief. In her new role, she will focus on supporting the editorial board to improve the visibility of JBB and to excel in the quality of the publications.
JMIR Bioinformatics and Biotechnology and JMIR Publications are thrilled to have Dr. Uzun on board and are looking forward to working with her in advancing the field of bioinformatics and biotechnology.
Click here to read the original press release.
